Your browser doesn't support javascript.
loading
Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors.
Hirotsu, Kelsey E; Scott, Madeleine K D; Marquez, Cesar; Tran, Anhthy T; Rieger, Kerri E; Novoa, Roberto A; Robinson, William H; Kwong, Bernice Y; Zaba, Lisa C.
Afiliação
  • Hirotsu KE; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California.
  • Scott MKD; Department of BioPhysics, Stanford University School of Medicine, Palo Alto, California.
  • Marquez C; Department of BioPhysics, Stanford University School of Medicine, Palo Alto, California.
  • Tran AT; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California.
  • Rieger KE; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Novoa RA; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Robinson WH; Division of Immunology & Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, California; VA Palo Alto Health Care System, Palo Alto, California.
  • Kwong BY; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California.
  • Zaba LC; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California. Electronic address: lisa.zaba@stanford.edu.
J Am Acad Dermatol ; 87(3): 651-653, 2022 09.
Article em En | MEDLINE | ID: mdl-34875301
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2022 Tipo de documento: Article